HemaSphere (Jun 2022)
P770: A COMPARATIVE STUDY OF LEUKEMIC TRANSFORMATION IN THERAPY-RELATED AND DE NOVO MYELODYSPLASTIC SYNDROME AFTER HYPOMETHYLATING AGENT FAILURE
- K. Kim,
- F. Ong,
- Z. Li,
- R. Kanagal-Shamanna,
- G. Montalban-Bravo,
- T. Kadia,
- E. Jabbour,
- N. Pemmaraju,
- D. Hammond,
- N. Short,
- F. Ravandi,
- Y. Alvarado,
- S. Pierce,
- X. Q. Dong,
- H. Kantarjian,
- G. Garcia-Manero,
- K. Chien
Affiliations
- K. Kim
- 1 Department of Leukemia
- F. Ong
- 1 Department of Leukemia
- Z. Li
- 2 Department of Biostatistics
- R. Kanagal-Shamanna
- 3 Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
- G. Montalban-Bravo
- 1 Department of Leukemia
- T. Kadia
- 1 Department of Leukemia
- E. Jabbour
- 1 Department of Leukemia
- N. Pemmaraju
- 1 Department of Leukemia
- D. Hammond
- 1 Department of Leukemia
- N. Short
- 1 Department of Leukemia
- F. Ravandi
- 1 Department of Leukemia
- Y. Alvarado
- 1 Department of Leukemia
- S. Pierce
- 1 Department of Leukemia
- X. Q. Dong
- 1 Department of Leukemia
- H. Kantarjian
- 1 Department of Leukemia
- G. Garcia-Manero
- 1 Department of Leukemia
- K. Chien
- 1 Department of Leukemia
- DOI
- https://doi.org/10.1097/01.HS9.0000845964.50511.34
- Journal volume & issue
-
Vol. 6
pp. 665 – 666
Abstract
No abstracts available.